INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 1999

Symptomatic gastroesophageal reflux was strongly associated with an increased risk of esophageal adenocarcinoma.

A nationwide population-based case-control study in Sweden evaluated the relationship between gastroesophageal reflux symptoms and esophageal or gastric cardia tumors. Compared with persons without recurrent reflux symptoms, those with recurrent symptoms had odds ratios of 7.7 (95% CI, 5.3 to 11.4) for esophageal adenocarcinoma and 2.0 (95% CI, 1.4 to 2.9) for adenocarcinoma of the cardia. For persons with long-standing and severe symptoms, odds ratios reached 43.5 (95% CI, 18.3 to 103.5) for esophageal adenocarcinoma and 4.4 (95% CI, 1.7 to 11.0) for cardia adenocarcinoma. Reflux symptoms were not associated with esophageal squamous-cell carcinoma (OR 1.1, 95% CI, 0.7 to 1.9).

Shows an association, not proof of cause and effect.

Study type
Population-based case-control study
Who was studied
189 esophageal adenocarcinoma, 262 cardia adenocarcinoma, and 167 esophageal squamous-cell carcinoma patients, plus 820 control subjects in Sweden
What was measured
Risk of esophageal adenocarcinoma, adenocarcinoma of the gastric cardia, and esophageal squamous-cell carcinoma

THE PAPER

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Lagergren J, Bergström R, Lindgren A, Nyrén O. N Engl J Med, 1999.

PubMed 10080844 ↗DOI 10.1056/nejm199903183401101 ↗

CancerGut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.